Cargando…
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
mTOR (mechanistic target of rapamycin) protein kinase acts as a central integrator of nutrient signaling pathways. Besides the immunosuppressive role after solid organ transplantations or in the treatment of some cancers, another promising role of mTOR inhibitor as an antiaging therapeutic has emerg...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035806/ https://www.ncbi.nlm.nih.gov/pubmed/30034573 http://dx.doi.org/10.1155/2018/2640342 |